Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, ...

Cellares is partnering with Stanford Medicine to automate gene-edited stem cell therapy for HIV and more than 19 rare diseases.

Researchers in the College of Agriculture, Health and Natural Resources have developed a novel line of bovine embryonic stem ...

We interviewed the renowned stem cell expert and founder of the regenerative skincare line about the inspiration behind the ...

Partsol today announced the release of their enhanced AI Stem Cells, a groundbreaking scientific breakthrough that redefines how artificial intelligence is designed, grown, and trusted. Revealed ...

“For many cell-based therapies, progress comes from connecting the right pieces at the right moment,” Klein said. “When ...

PrimeGen US, Inc. (“PrimeGen US" or the "Company”), a pioneering biotech company advancing innovative stem cell and exosome therapies, today announced it has entered into a definitive business ...

Vertex executives warned that Casgevy, its curative treatment for sickle cell disease, would be slow to reach patients. But ...

Cell and gene therapy company ENCell said on the 6th that its allogeneic umbilical cord-derived mesenchymal stem cell therapy candidate "EN001" received orphan drug designation (ODD) from the U.S.

Introducing cell therapy--grade cryopreservation and hypothermic storage solutions designed for consistency, quality, and performance across cell therapy workflows ST. PETERSBURG, Fla., Feb. 6, 2026 ...